Good timing on this article if Fillerina starts being distributed as planned in the next month.
Hope there are no further delays and the 70% of the first shipment distributed has grown to the point of reorder.
Busy times ahead with the Japanese market if the planned Pharmacy Product launch into pharmacies goes ahead presumably straight after the second tranche of the placement is approved.
Dont know what the rollout plans are for NZ, no evidence of either Fillerina or Evolis in pharmacies locally, yet.
CDY Price at posting:
38.5¢ Sentiment: Buy Disclosure: Held